Sorrento Therapeutics, Inc. also files under SRNE, OTCQB:SRNE, QBSW, QBYT; those filings are included.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 17, 2023 | Ji Henry | See Remarks, Director | Option exercise(X) | 20K | $0.80 | $16K |
| Mar 17, 2023 | Ji Henry | See Remarks, Director | Disposed to issuer(D) | 195 | — | $0 |
| Dec 21, 2022 | Ji Henry | See Remarks, Director | Option exercise(X) | 3 | — | $0 |
| Dec 21, 2022 | Ji Henry | See Remarks, Director | Option exercise(X) | 300 | $5.50 | $2K |
| Dec 15, 2022 | Ji Henry | See Remarks, Director | Grant(A) | 1.5M | — | $0 |
| Dec 2, 2022 | Ji Henry | See Remarks, Director | Option exercise(X) | 200 | $5.50 | $1K |
| Dec 2, 2022 | Ji Henry | See Remarks, Director | Option exercise(X) | 2 | — | $0 |
| Sep 7, 2022 | Ji Henry | See Remarks, Director | Buy(P) | 129 | $41.66as filed | — |
| Sep 7, 2022 | Ji Henry | See Remarks, Director | Buy(P) | 89K | $2.02 | $180K |
| Sep 7, 2022 | Ji Henry | See Remarks, Director | Buy(P) | 759 | $40.66as filed | — |
| Sep 6, 2022 | Ji Henry | See Remarks, Director | Buy(P) | 56K | $1.96 | $109K |
| Sep 2, 2022 | Ji Henry | See Remarks, Director | Grant(A) | 2.5M | — | $0 |
| Aug 26, 2022 | Ji Henry | See Remarks, Director | Sell(S) | 200 | $349.33as filed | — |
| Aug 26, 2022 | Ji Henry | See Remarks, Director | Buy(P) | 33K | $2.11 | $70K |
| Aug 25, 2022 | Ji Henry | See Remarks, Director | Buy(P) | 22K | $2.06 | $46K |
| Aug 25, 2022 | Ji Henry | See Remarks, Director | Buy(P) | 1K | $30.66as filed | — |
| Jun 14, 2022 | Ji Henry | See Remarks, Director | Buy(P) | 10K | $1.40 | $14K |
| May 18, 2022 | Reilly Tammy | Director | Grant(A) | 100K | — | $0 |
| May 18, 2022 | Czerepak Elizabeth | EVP & Chief Financial Officer | Grant(A) | 350K | — | $0 |
| Dec 27, 2021 | Janda Kim | Director | Option exercise(M) | 3K | — | $0 |
| Dec 27, 2021 | Janda Kim | Director | Option exercise(M) | 3K | $4.00 | $12K |
| Dec 27, 2021 | Janda Kim | Director | Sell(S) | 3K | $5.88 | $18K |
| Nov 18, 2021 | Czerepak Elizabeth | Director | Grant(A) | 100K | — | $0 |
| Sep 29, 2021 | Ji Henry | See Remarks, Director | Option exercise(M) | 10K | $4.00 | $40K |
| Sep 29, 2021 | Ji Henry | See Remarks, Director | Option exercise(M) | 10K | — | $0 |
| Sep 27, 2021 | Janda Kim | Director | Option exercise(M) | 35K | — | $0 |
| Sep 27, 2021 | Janda Kim | Director | Sell(S) | 42K | $8.02 | $340K |
| Sep 27, 2021 | Janda Kim | Director | Option exercise(M) | 7K | — | $0 |
| Sep 27, 2021 | Janda Kim | Director | Option exercise(M) | 7K | $3.57 | $26K |
| Sep 27, 2021 | Janda Kim | Director | Option exercise(M) | 35K | $1.80 | $63K |
| Sep 13, 2021 | Janda Kim | Director | Sell(S) | 8K | $8.04 | $64K |
| Sep 13, 2021 | Janda Kim | Director | Option exercise(M) | 8K | $3.50 | $28K |
| Sep 13, 2021 | Janda Kim | Director | Option exercise(M) | 8K | — | $0 |
| Sep 3, 2021 | Smith Robin L | Director | Option exercise(M) | 100K | $4.89 | $489K |
| Sep 3, 2021 | Smith Robin L | Director | Option exercise(M) | 100K | — | $0 |
| Sep 3, 2021 | Smith Robin L | Director | Option exercise(M) | 75K | — | $0 |
| Sep 3, 2021 | Smith Robin L | Director | Option exercise(M) | 75K | $3.95 | $296K |
| Aug 30, 2021 | Ji Henry | See Remarks, Director | Grant(A) | 2.5M | — | $0 |
| Aug 30, 2021 | Smith Robin L | Director | Grant(A) | 250K | — | $0 |
| Aug 30, 2021 | Wu Yue Alexander | Director | Grant(A) | 250K | — | $0 |
| Aug 30, 2021 | Shah Jaisim | Director | Grant(A) | 250K | — | $0 |
| Aug 30, 2021 | Lemus David | Director | Grant(A) | 250K | — | $0 |
| Aug 30, 2021 | Janda Kim | Director | Grant(A) | 250K | — | $0 |
| Aug 30, 2021 | Followwill Dorman | Director | Grant(A) | 250K | — | $0 |
| Apr 12, 2021 | Janda Kim | Director | Sell(S) | 2K | $6.97 | $13K |
| Apr 12, 2021 | Janda Kim | Director | Option exercise(M) | 2K | $3.50 | $7K |
| Apr 12, 2021 | Janda Kim | Director | Option exercise(M) | 2K | — | $0 |
| Mar 16, 2021 | Asghar Najjam | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Mar 16, 2021 | Asghar Najjam | Chief Financial Officer | Grant(A) | 57K | — | $0 |
| Dec 16, 2020 | Followwill Dorman | Director | Sell(S) | 1K | $7.14 | $7K |
| Nov 12, 2020 | Asghar Najjam | Chief Financial Officer | Grant(A) | 120K | — | $0 |
| Nov 11, 2020 | Followwill Dorman | Director | Inheritance(W) | 1K | — | $0 |
| Oct 16, 2020 | Ji Henry | See Remarks, Director | Grant(A) | 24.9M | — | $0 |
| Aug 7, 2020 | Janda Kim | Director | Grant(A) | 150K | — | $0 |
| Jun 15, 2020 | Ji Henry | See Remarks, Director | Grant(A) | 1.5M | — | $0 |
| Jun 15, 2020 | Lee Edgar | Director | Grant(A) | 100K | — | $0 |
| Jun 15, 2020 | Smith Robin L | Director | Grant(A) | 100K | — | $0 |
| Jun 15, 2020 | Shao Jiong | Chief Financial Officer | Grant(A) | 120K | — | $0 |
| Jun 15, 2020 | Shah Jaisim | Director | Grant(A) | 100K | — | $0 |
| Jun 15, 2020 | Lemus David | Director | Grant(A) | 100K | — | $0 |
| Jun 15, 2020 | Followwill Dorman | Director | Grant(A) | 100K | — | $0 |
| Jun 15, 2020 | Wu Yue Alexander | Director | Grant(A) | 100K | — | $0 |
| Jun 15, 2020 | Janda Kim | Director | Grant(A) | 100K | — | $0 |
| Mar 5, 2020 | Smith Robin L | Director | Buy(P) | 40K | $2.27 | $91K |
| Dec 16, 2019 | Smith Robin L | Director | Grant(A) | 75K | — | $0 |
| Dec 9, 2019 | Lee Edgar | Director | Grant(A) | 75K | — | $0 |
| Apr 19, 2019 | Shao Jiong | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Apr 19, 2019 | Wu Yue Alexander | Director | Grant(A) | 70K | — | $0 |
| Apr 19, 2019 | Shah Jaisim | Director | Grant(A) | 70K | — | $0 |
| Apr 19, 2019 | Lemus David | Director | Grant(A) | 70K | — | $0 |
| Apr 19, 2019 | Followwill Dorman | Director | Grant(A) | 70K | — | $0 |
| Apr 19, 2019 | Janda Kim | Director | Grant(A) | 70K | — | $0 |
| Apr 19, 2019 | Ji Henry | See Remarks, Director | Grant(A) | 1.5M | — | $0 |
| Nov 26, 2018 | Followwill Dorman | Director | Grant(A) | 35K | — | $0 |
| Nov 26, 2018 | Zeldis Jerome B | See Remarks | Grant(A) | 100K | — | $0 |
| Nov 26, 2018 | Janda Kim | Director | Grant(A) | 35K | — | $0 |
| Nov 26, 2018 | Shao Jiong | Chief Financial Officer | Grant(A) | 100K | — | $0 |
| Nov 26, 2018 | Wu Yue Alexander | Director | Grant(A) | 35K | — | $0 |
| Nov 26, 2018 | Shah Jaisim | Director | Grant(A) | 35K | — | $0 |
| Nov 26, 2018 | Lemus David | Director | Grant(A) | 35K | — | $0 |
| Sep 13, 2018 | ABG Management Ltd | 10% Owner | Sell(S) | 29K | $5.01 | $146K |
| Sep 13, 2018 | ABG Management Ltd | 10% Owner | Sell(S) | 79K | $4.92 | $387K |
| Sep 12, 2018 | ABG Management Ltd | 10% Owner | Sell(S) | 190K | $5.06 | $960K |
| Jul 20, 2018 | Ji Henry | See Remarks, Director | Option exercise(M) | 6K | $1.75 | $11K |
| Jul 20, 2018 | Ji Henry | See Remarks, Director | Option exercise(M) | 6K | — | $0 |
| May 17, 2018 | Ji Henry | See Remarks, Director | Grant(A) | 750K | — | $0 |
| Feb 28, 2018 | Ng George K | See Remarks | Buy(P) | 90K | $9.95 | $896K |
| Feb 28, 2018 | Ji Henry | See Remarks, Director | Buy(P) | 65K | $9.95 | $643K |
| Feb 28, 2018 | Ng George K | See Remarks | Other(J) | 163K | — | — |
| Feb 28, 2018 | Ji Henry | See Remarks, Director | Other(J) | 124K | — | — |
| Feb 28, 2018 | Ferrigno Dean | Chief Accounting Officer | Other(J) | 118 | — | — |
| Feb 7, 2018 | Yu Fan | 10% Owner | Sell(S) | 150K | $7.19 | $1.1M |
| Feb 6, 2018 | Yu Fan | 10% Owner | Sell(S) | 513K | $6.75 | $3.5M |
| Feb 5, 2018 | Ally Bridge Group Capital Partners II, L.P. | 10% Owner | Sell(S) | 37K | $8.00 | $300K |
| Feb 5, 2018 | Ally Bridge Group Capital Partners II, L.P. | 10% Owner | Sell(S) | 17K | $8.00 | $136K |
| Feb 5, 2018 | Ally Bridge Group Capital Partners II, L.P. | 10% Owner | Sell(S) | 16K | $8.00 | $130K |
| Jan 30, 2018 | ABG Management Ltd | 10% Owner | Sell(S) | 57K | $7.65 | $436K |
| Jan 30, 2018 | ABG Management Ltd | 10% Owner | Sell(S) | 54K | $7.65 | $411K |
| Jan 30, 2018 | ABG Management Ltd | 10% Owner | Sell(S) | 124K | $7.65 | $951K |
| Jan 29, 2018 | ABG Management Ltd | 10% Owner | Sell(S) | 18K | $7.61 | $137K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Sorrento Therapeutics, Inc., SEC CIK 0000850261. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under SRNEQ and shows every filing by that issuer (also filed as SRNE, OTCQB:SRNE, QBSW, QBYT).
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-12. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for SRNEQ